Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / Atle Fund Management AB
Form 13F · Q2 2026

Atle Fund Management AB

CIK 1381843申報日 2026-07-2413F-HR 在 EDGAR 查看原始申報 ↗
$3.7亿
申報組合市值
39
持倉數量
11
Quarters on record
Top 50
持倉數量

Atle Fund Management AB——持倉

共 39 個持倉中的前 39 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1LLY Eli Lilly & Co29,821−24.9%$3577万9.6%
2MRK Merck & Co Inc189,357+459.4%$2433万6.5%
3JNJ Johnson & Johnson85,425−7.5%$2170万5.8%
4ABBV Abbvie Inc64,325−40.5%$1619万4.4%
5CVS Cvs Health Corp146,102+514.6%$1511万4.1%
6TMO Thermo Fisher Scientific Inc27,859+21.2%$1397万3.8%
7RVMD Revolution Medicines Inc73,077−88.2%$1369万3.7%
8BIIB Biogen Inc62,781—$1356万3.6%
9NBIX Neurocrine Biosciences Inc72,898−18.7%$1229万3.3%
10MIRM Mirum Pharmaceuticals Inc100,807−48.5%$1180万3.2%
11ALKS Alkermes Plc213,329−12.0%$1118万3.0%
12IONS Ionis Pharmaceuticals Inc137,131+392.0%$1087万2.9%
13ONC Beone Medicines Ltd35,180−15.7%$1003万2.7%
14ISRG Intuitive Surgical Inc24,656−65.2%$981万2.6%
15SYK Stryker Corporation30,283+12.8%$953万2.6%
16VRTX Vertex Pharmaceuticals Inc19,131−16.8%$950万2.6%
17EW Edwards Lifesciences Corp103,230−3.1%$934万2.5%
18BBIO Bridgebio Pharma Inc124,707+12.0%$929万2.5%
19KRYS Krystal Biotech Inc24,019−36.1%$893万2.4%
20COR Cencora Inc31,126+32.6%$881万2.4%
21NAMS Newamsterdam Pharma Company248,848+162.5%$843万2.3%
22ABVX Abivax Sa58,170+84.1%$775万2.1%
23INCY Incyte Corp56,953+12.1%$646万1.7%
24IRTC Irhythm Holdings Inc54,102+142.4%$644万1.7%
25BSX Boston Scientific Corp146,381+262.0%$625万1.7%
26INSM Insmed Inc58,378−40.1%$622万1.7%
27TNGX Tango Therapeutics Inc198,557+563.7%$621万1.7%
28GILD Gilead Sciences Inc46,142−3.8%$583万1.6%
29CAH Cardinal Health Inc23,630−78.3%$561万1.5%
30ORKA Oruka Therapeutics Inc54,886—$522万1.4%
31SYRE Spyre Therapeutics Inc57,030−9.1%$506万1.4%
32DXCM Dexcom Inc71,846−87.7%$484万1.3%
33BCAX Bicara Therapeutics Inc145,657−87.5%$432万1.2%
34IDYA Ideaya Biosciences Inc94,478+203.5%$352万0.9%
35CELC Celcuity Inc33,313−76.4%$349万0.9%
36IRON Disc Medicine Inc43,682−59.3%$319万0.9%
37PYXS Pyxis Oncology Inc966,459+390.5%$291万0.8%
38CMPX Compass Therapeutics Inc1.0M+2406.7%$230万0.6%
39JBIO Jade Biosciences Inc88,556—$197万0.5%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。